Cx 1 Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 2024
DOI: 10.1089/mab.2023.0031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2024. Verfasst von Guanjie Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Yukinari Kato
Zitieren
APA
Li, G., Tanaka, T., Ouchida, T., Kaneko, M. K., Suzuki, H., & Kato, Y. (2024). Cx 1 Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. https://doi.org/10.1089/mab.2023.0031
Vancouver
Li G, Tanaka T, Ouchida T, Kaneko MK, Suzuki H, Kato Y. Cx 1 Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2024. doi:10.1089/mab.2023.0031
BibTeX
@article{Li2024,
author = {Li, Guanjie and Tanaka, Tomohiro and Ouchida, Tsunenori and Kaneko, Mika K and Suzuki, Hiroyuki and Kato, Yukinari},
title = {Cx 1 Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry},
journal = {Monoclonal Antibodies in Immunodiagnosis and Immunotherapy},
year = {2024},
doi = {10.1089/mab.2023.0031}
}
EUVIMED